| PubMed |
Abstract |
RScore(About this table) |
| 2971621 |
Sullam PM, Jarvis GA, Valone FH: Role of immunoglobulin G in platelet aggregation by viridans group streptococci. Infect Immun. 1988 Nov;56(11):2907-11.
|
2(0,0,0,2) |
Details |
| 21340841 |
Kaufman PA, Wallace PK, Valone FH, Wells WA, Memoli VA, Ernstoff MS: Bispecific Antibody MDX-210 for Treatment of Advanced Ovarian and Breast Cancer. Methods Mol Med. 2001;39:793-806.
Additionally, although humanized MAbs are being developed, when used therapeutically their immunological effectiveness may be limited by high concentrations of nonspecific immunoglobulin (Ig) in patient serum. |
1(0,0,0,1) |
Details |
| 7545221 |
Valone FH, Kaufman PA, Guyre PM, Lewis LD, Memoli V, Deo Y, Graziano R, Fisher JL, Meyer L, Mrozek-Orlowski M, et al.: Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu. J Clin Oncol. 1995 Sep;13(9):2281-92.
PURPOSE: MDX-210 is a bispecific antibody that binds simultaneously to type I Fc receptors for immunoglobulin G (IgG) (Fc gamma RI) and to the HER-2/neu oncogene protein product. |
1(0,0,0,1) |
Details |